Abstract
It is shown that 3-(3-[1,2,4]-triazolo)-oxatriazolium-5-olate (azasidnon-6) can act directly on the vascular wall of isolated segments of caudal ventral artery of SHR rats. Using heme-dependent soluble guanyl cyclase inhibitor 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), it has been found that one of the possible mechanisms of azasidnon-6 vasodilatory action includes heme-dependent activation of a soluble form of guanylate cyclase.
MeSH terms
-
Animals
-
Arteries / drug effects*
-
Guanylate Cyclase / antagonists & inhibitors
-
Guanylate Cyclase / metabolism
-
Heme / metabolism
-
Male
-
Nitric Oxide / metabolism
-
Nitroprusside / pharmacology
-
Oxadiazoles / pharmacology
-
Phenylephrine / pharmacology
-
Quinoxalines / pharmacology
-
Rats
-
Rats, Inbred SHR
-
Rats, Wistar
-
Tail / blood supply
-
Tissue Culture Techniques
-
Triazoles / pharmacology*
-
Vasoconstrictor Agents / pharmacology
-
Vasodilation / drug effects*
-
Vasodilator Agents / pharmacology*
Substances
-
1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one
-
3-(3-(1,2,4)-triazolo)-oxatriazolium-5-olate
-
Oxadiazoles
-
Quinoxalines
-
Triazoles
-
Vasoconstrictor Agents
-
Vasodilator Agents
-
Nitroprusside
-
Phenylephrine
-
Nitric Oxide
-
Heme
-
Guanylate Cyclase